Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Pediatr Adolesc Gynecol ; 34(5): 597-602, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33989804

ABSTRACT

STUDY OBJECTIVE: To assess long-term outcomes of lichen sclerosus (LS) in the female pediatric population, specifically in relation to patient age, treatment type and duration, and remission. DESIGN, SETTING, PARTICIPANTS, INTERVENTIONS, AND MAIN OUTCOME MEASURES: Retrospective chart review was conducted to identify female pediatric patients (0-18 years of age) who were diagnosed with LS between January 1, 2015 and January 1, 2020 at the University of North Carolina Dermatology and/or Obstetrics and Gynecology Departments. Patients were contacted via telephone for follow-up interviews consisting of a series of questions regarding patient age, symptom onset, time of diagnosis, treatment, and current symptoms. RESULTS: Of the 128 patients identified, 61 patients consented and participated in follow-up interviews. At the time of study follow-up, 55/61 (90%) of participants reported their symptoms were improved. Patients reported using a variety of treatments, with medium- to high-potency topical steroids being the most common. At the time of follow-up, 53/61 (87%) of patients reported being asymptomatic, 37/53 (70%) of whom were not using any form of maintenance therapy. Those who achieved symptom resolution did so at an average of 8.4 years of age. There was no significant difference in age in asymptomatic patients receiving maintenance therapy and those receiving no maintenance therapy. There was a positive correlation for the duration of LS treatment and time in remission (P < .001). Increased patient age at time of follow-up also correlated positively with time in remission (P < .001). CONCLUSION: In our cohort, the need for continued maintenance therapy was not correlated with age or, by proxy, pubertal status. Thus, LS remission might be determined more by early and successful pharmacological interventions.


Subject(s)
Lichen Sclerosus et Atrophicus , Vulvar Diseases , Vulvar Lichen Sclerosus , Child , Female , Glucocorticoids , Humans , Retrospective Studies , Surveys and Questionnaires , Vulvar Lichen Sclerosus/diagnosis , Vulvar Lichen Sclerosus/drug therapy
3.
Pediatr Dermatol ; 34(3): e130-e131, 2017 May.
Article in English | MEDLINE | ID: mdl-28239912

ABSTRACT

Burn injuries are known to compromise host immune defenses through disruption of mucocutaneous barriers and suppression of cell-mediated immune responses, which may render patients with burn injuries susceptible to viral infections in the days to years after an initial insult. We report a case of verrucae planae developing as a secondary condition confined to former xenograft sites in a child, appearing more than 3.5 years after initial second-degree burn injuries. Only a few reports have previously described the development of verrucae in former burn sites, with most reporting latency to onset of verrucae appearance of months rather than years. Current hypotheses suggest that the postburn immune response shifts from an early proinflammatory to a late antiinflammatory response characterized by altered cytokine profiles and diminished cellular cytotoxicity mediated by cytotoxic T-lymphocytes, natural killer cells, and epidermal antigen-presenting cells, which together likely contribute to an enduring postburn regional immunosuppression that allows for the seeding and proliferation of viral agents.


Subject(s)
Burns/surgery , Heterografts/pathology , Skin Diseases/pathology , Skin Transplantation/adverse effects , Warts/pathology , Administration, Topical , Aminoquinolines/therapeutic use , Burns/complications , Burns/diagnosis , Burns/immunology , Child, Preschool , Follow-Up Studies , Heterografts/immunology , Humans , Imiquimod , Immunocompromised Host , Injury Severity Score , Male , Rare Diseases , Severity of Illness Index , Skin Diseases/drug therapy , Skin Diseases/etiology , Skin Transplantation/methods , Treatment Outcome , Warts/drug therapy , Warts/etiology
4.
Hear Res ; 333: 25-36, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26724756

ABSTRACT

Early hearing loss leads to crossmodal plasticity in regions of the cerebrum that are dominated by acoustical processing in hearing subjects. Until recently, little has been known of the connectional basis of this phenomenon. One region whose crossmodal properties are well-established is the auditory field of the anterior ectosylvian sulcus (FAES) in the cat, where neurons are normally responsive to acoustic stimulation and its deactivation leads to the behavioral loss of accurate orienting toward auditory stimuli. However, in early-deaf cats, visual responsiveness predominates in the FAES and its deactivation blocks accurate orienting behavior toward visual stimuli. For such crossmodal reorganization to occur, it has been presumed that novel inputs or increased projections from non-auditory cortical areas must be generated, or that existing non-auditory connections were 'unmasked.' These possibilities were tested using tracer injections into the FAES of adult cats deafened early in life (and hearing controls), followed by light microscopy to localize retrogradely labeled neurons. Surprisingly, the distribution of cortical and thalamic afferents to the FAES was very similar among early-deaf and hearing animals. No new visual projection sources were identified and visual cortical connections to the FAES were comparable in projection proportions. These results support an alternate theory for the connectional basis for cross-modal plasticity that involves enhanced local branching of existing projection terminals that originate in non-auditory as well as auditory cortices.


Subject(s)
Auditory Cortex/physiopathology , Hearing Loss/physiopathology , Hearing , Neuronal Plasticity , Thalamus/physiopathology , Visual Cortex/physiopathology , Acoustic Stimulation , Adaptation, Physiological , Age Factors , Animals , Auditory Cortex/growth & development , Auditory Pathways/physiopathology , Auditory Perception , Cats , Disease Models, Animal , Hearing Loss/chemically induced , Hearing Loss/psychology , Kanamycin , Neuroanatomical Tract-Tracing Techniques , Photic Stimulation , Thalamus/growth & development , Visual Cortex/growth & development , Visual Perception
SELECTION OF CITATIONS
SEARCH DETAIL
...